Prolactin has a pathogenic role in systemic lupus erythematosus (original) (raw)

• Afanasyeva M, Rose RN. Viral infection and heart disease: autoimmune mechanisms. In: Shoenfeld Y, Rose NR, editors. Infections and autoimmunity. The Netherlands: Elsevier B.V.; 2004. pp. 299–318.
• Dar AA, Patil RS, Chiplunkar SV. Insights into the relationship between toll like receptors and gamma delta T cell responses. Front Immunol. 2014;5:366.
  Article PubMed PubMed Central CAS Google Scholar
• Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev. 1996;17:64–102.
  Article CAS PubMed Google Scholar
• Jara LJ, Lavalle C, Espinoza LR. Does prolactin have a role in the pathogenesis of systemic lupus erythematosus? J Rheumatol. 1992;19:1333–6.
  CAS PubMed Google Scholar
• Szyper-Kravitz M, Zandman-Goddard G, Lahita RG, Shoenfeld Y. The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity. Rheum Dis Clin N Am. 2005;31:161–75.
  Article Google Scholar
• Berczi I, Bertok L, Chow DA. Natural immunity and neuroimmune host defense. Ann N Y Acad Sci. 2000;917:248–57.
  Article CAS PubMed Google Scholar
• Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol. 1995;13:307–38.
  Article CAS PubMed Google Scholar
• De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A. Prolactin and autoimmunity. Pituitary. 2005;8:25–30.
  Article PubMed CAS Google Scholar
• Breuel KF, Kougias P, Rice PJ, Wei D, De Ponti K, Wang J, et al. Anterior pituitary cells express pattern recognition receptors for fungal glucans: implications for neuroendocrine immune involvement in response to fungal infections. Neuroimmunomodulation. 2004;11:1–9.
  Article PubMed CAS Google Scholar
• Peña B, Isla A, Haussmann D, Figueroa J. Immunostimulatory effect of salmon prolactin on expression of toll-like receptors in Oncorhynchus mykiss infected with Piscirickettsia salmonis. Fish Physiol Biochem. 2016;42:509–16.
  Article PubMed CAS Google Scholar
• Corbacho AM, Valacchi G, Kubala L, Olano-Martín E, Schock BC, Kenny TP, et al. Tissue-specific gene expression of prolactin receptor in the acute-phase response induced by lipopolysaccharides. Am J Physiol Endocrinol Metab. 2004;287:E750–7.
  Article CAS PubMed Google Scholar
• Meli R, Raso GM, Gualillo O, Pacilio M, Di Carlo RR. Prolactin modulation of nitric oxide and TNF-alpha production by peripheral neutrophils in rats. Life Sci. 1997;61:1395–403.
  Article CAS PubMed Google Scholar
• Dal Secco D, Paron JA, de Oliveira SH, Ferreira SH, Silva JS, Cunha FQ. Neutrophil migration in inflammation: nitric oxide inhibits rolling, adhesion and induces apoptosis. Nitric Oxide. 2003;9:153–64.
  Article CAS PubMed Google Scholar
• Olson KK, Townson DH. Prolactin-induced expression of intercellular adhesion molecule-1 and the accumulation of monocytes/macrophages during regression of the rat corpus luteum. Biol Reprod. 2000;62:1571–8.
  Article CAS PubMed Google Scholar
• Kawaguchi R, Shimokawa T, Umehara N, Nunomura S, Tanaka T, Ra C. Priming of peripheral monocytes with prolactin (PRL) sensitizes IFN-gamma-mediated indoleamine 2,3-dioxygenase (IDO) expression without affecting IFN-gamma signaling. J Reprod Immunol. 2008;77:117–25.
  Article CAS PubMed Google Scholar
• Torres-Aguilar H, Blank M, Jara LJ, Shoenfeld Y. Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity. Autoimmun Rev. 2010;10:8–17.
  Article CAS PubMed Google Scholar
• Matera L, Mori M, Galetto A. Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. Lupus. 2001;10:728–34.
  Article CAS PubMed Google Scholar
• Triggianese P, Perricone C, Perricone R, De Carolis C. Prolactin and natural killer cells: evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion. Am J Reprod Immunol. 2015;73:56–65.
  Article CAS PubMed Google Scholar
• Gubbay O, Critchley HO, Bowen JM, King A, Jabbour HN. Prolactin induces ERK phosphorylation in epithelial and CD56(+) natural killer cells of the human endometrium. J Clin Endocrinol Metab. 2002;87:2329–35.
  Article CAS PubMed Google Scholar
• Francis K, Lewis BM, Akatsu H, Monk PN, Cain SA, Scanlon MF, et al. Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation. FASEB J. 2003;17:2266–8.
  CAS PubMed Google Scholar
• Brand JM, Frohn C, Cziupka K, Brockmann C, Kirchner H, Luhm J. Prolactin triggers pro-inflammatory immune responses in peripheral immune cells. Eur Cytokine Netw. 2004;15:99–104.
  CAS PubMed Google Scholar
• D’Isanto M, Vitiello M, Raieta K, Galdiero M, Galdiero M. Prolactin modulates IL-8 production induced by porins or LPS through different signaling mechanisms. Immunobiology. 2004;209:523–33.
  Article PubMed CAS Google Scholar
• Montgomery DW, Shen GK, Ulrich ED, Steiner LL, Parrish PR, Zukoski CF. Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins. Endocrinology. 1992;131:3019–26.
  Article CAS PubMed Google Scholar
• Pellegrini I, Lebrun JJ, Ali S, Kelly PA. Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol. 1992;6:1023–31.
  CAS PubMed Google Scholar
• Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, et al. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 1997;16:6926–35.
  Article CAS PubMed PubMed Central Google Scholar
• Dogusan Z, Hooghe R, Verdood P, Hooghe-Peters EL. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes. J Neuroimmunol. 2001;120:58–66.
  Article CAS PubMed Google Scholar
• Lahat N, Miller A, Shtiller R, Touby E. Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J Neuroimmunol. 1993;47:35–40.
  Article CAS PubMed Google Scholar
• Matalka KZ. Prolactin enhances production of interferon-gamma, interleukin-12, and interleukin-10, but not of tumor necrosis factor-alpha, in a stimulus-specific manner. Cytokine. 2003;21:187–94.
  Article CAS PubMed Google Scholar
• Matera L, Contarini M, Bellone G, Forno B, Biglino A. Up-modulation of interferon-gamma mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cells. Immunology. 1999;98:386–92.
  Article CAS PubMed PubMed Central Google Scholar
• Leff MA, Buckley DJ, Krumenacker JS, Reed JC, Miyashita T, Buckley AR. Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. Endocrinology. 1996;137:5456–62.
  Article CAS PubMed Google Scholar
• Krishnan N, Thellin O, Buckley DJ, Horseman ND, Buckley AR. Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo. Endocrinology. 2003;144:2102–10.
  Article CAS PubMed Google Scholar
• Zellweger R, Zhu XH, Wichmann MW, Ayala A, DeMaso CM, Chaudry IH. Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J Immunol. 1996;157:5748–54.
  CAS PubMed Google Scholar
• Dugan AL, Thellin O, Buckley DJ, Buckley AR, Ogle CK, Horseman ND. Effects of prolactin deficiency on myelopoiesis and splenic T lymphocyte proliferation in thermally injured mice. Endocrinology. 2002;143:4147–51.
  Article CAS PubMed Google Scholar
• Gerlo S, Verdood P, Hooghe-Peters EL, Kooijman R. Modulation of prolactin expression in human T lymphocytes by cytokines. J Neuroimmunol. 2005;162:190–3.
  Article CAS PubMed Google Scholar
• Takizawa K, Kitani S, Takeuchi F, Yamamoto K. Enhanced expression of CD69 and CD25 antigen on human peripheral blood mononuclear cells by prolactin. Endocr J. 2005;52:635–41.
  Article CAS PubMed Google Scholar
• Kochendoerfer SK, Krishnan N, Buckley DJ, Buckley AR. Prolactin regulation of Bcl-2 family members: increased expression of bcl-xL but not mcl-1 or bad in Nb2-T cells. J Endocrinol. 2003;178:265–73.
  Article CAS PubMed Google Scholar
• Gerlo S, Verdood P, Gellersen B, Hooghe-Peters EL, Kooijman R. Mechanism of prostaglandin (PG)E2-induced prolactin expression in human T cells: cooperation of two PGE2 receptor subtypes, E-prostanoid (EP) 3 and EP4, via calcium- and cyclic adenosine 5′-monophosphate-mediated signaling pathways. J Immunol. 2004;173:5952–62.
  Article CAS PubMed Google Scholar
• Morales P, Carretero MV, Geronimo H, Copín SG, Gaspar ML, Marcos MA, et al. Influence of prolactin on the differentiation of mouse B-lymphoid precursors. Cell Growth Differ. 1999;10:583–90.
  CAS PubMed Google Scholar
• Chavez-Rueda K, Hérnández J, Zenteno E, Leaños-Miranda A, Legorreta-Haquet MV, Blanco-Favela F. Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes. Clin Immunol. 2005;116:182–91.
  Article CAS PubMed Google Scholar
• Gonzalez J, Saha S, Peeva E. Prolactin rescues and primes autoreactive B cells directly and indirectly through dendritic cells in B6.Sle3 mice. Clin Exp Immunol. 2013;172:311–20.
  Article CAS PubMed PubMed Central Google Scholar
• Hartwell HJ, Petrosky KY, Fox JG, Horseman ND, Rogers AB. Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice. Proc Natl Acad Sci U S A. 2014;111:11455–60.
  Article CAS PubMed PubMed Central Google Scholar
• Adán N, Guzmán-Morales J, Ledesma-Colunga MG, Perales-Canales SI, Quintanar-Stéphano A, López-Barrera F, et al. Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis. J Clin Invest. 2013;123:3902–13.
  Article PubMed PubMed Central CAS Google Scholar
• McCoy JM, Walkenhorst DE, McCauley KS, Elaasar H, Everett JR, Mix KS. Orphan nuclear receptor NR4A2 induces transcription of the immunomodulatory peptide hormone prolactin. J Inflamm (Lond). 2015;12:13. doi:10.1186/s12950-015-0059-2.
• López-Rincón G, Pereira-Suárez AL, Del Toro-Arreola S, Sánchez-Hernández PE, Ochoa-Zarzosa A, Muñoz-Valle JF, et al. Lipopolysaccharide induces the expression of an autocrine prolactin loop enhancing inflammatory response in monocytes. J Inflamm (Lond). 2013;10:24. doi:10.1186/1476-9255-10-24.
• Costanza M, Binart N, Steinman L, Pedotti R. Prolactin: a versatile regulator of inflammation and autoimmune pathology. Autoimmun Rev. 2015;14:223–30.
  Article CAS PubMed Google Scholar
• Pereira Suarez AL, López-Rincón G, Martínez Neri PA, Estrada-Chávez C. Prolactin in inflammatory response. Adv Exp Med Biol. 2015;846:243–64.
  Article PubMed CAS Google Scholar
• Brennan P, Hajeer A, Ong KR, Worthington J, John S, Thomson W, et al. Allelic markers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 1997;40:1383–6.
  Article CAS PubMed Google Scholar
• Stevens A, Ray D, Alansari A, Hajeer A, Thomson W, Donn R, et al. Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum. 2001;44:2358–66.
  Article CAS PubMed Google Scholar
• Mellai M, Giordano M, D’Alfonso S, Marchini M, Scorza R, Giovanna Danieli M, et al. Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. Hum Immunol. 2003;64:274–84.
  Article CAS PubMed Google Scholar
• Montoya-Diaz E, Cervera-Castillo H, Chávez-Sánchez L, Legorreta-Haquet MV, Sánchez-González L, Chávez-Rueda K, et al. Prolactin promoter polymorphism (-1149 G/T) is associated with anti-DNA antibodies in Mexican patients with systemic lupus erythematosus. Immunol Investig. 2011;40:614–26.
  Article CAS Google Scholar
• Lee YH, Bae SC, Song GG. Meta-analysis of associations between functional prolactin -1149 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol. 2015;34:683–90.
  Article PubMed Google Scholar
• Treadwell EL, Wiley K, Word B, Melchior W, Tolleson WH, Gopee N, et al. Prolactin and Dehydroepiandrosterone Levels in Women with Systemic Lupus Erythematosus: The Role of the Extrapituitary Prolactin Promoter Polymorphism at -1149G/T. J Immunol Res. 2015;2015:435658. doi:10.1155/2015/435658.
• McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol. 1991;147:3780–7.
  CAS PubMed Google Scholar
• Blank M, Krause I, Buskila D, Teitelbaum D, Kopolovic J, Afek A, et al. Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells. Cell Immunol. 1995;162:114–22.
  Article CAS PubMed Google Scholar
• McMurray RW. Prolactin in murine systemic lupus erythematosus. Lupus. 2001;10:742–7.
  Article CAS PubMed Google Scholar
• Peeva E, Grimaldi C, Spatz L, Diamond B. Bromocriptine restores tolerance in estrogen-treated mice. J Clin Invest. 2000;106:1373–9.
  Article CAS PubMed PubMed Central Google Scholar
• Peeva E, Michael D, Cleary J, Rice J, Chen X, Diamond B. Prolactin modulates the naive B cell repertoire. J Clin Invest. 2003;111:275–83.
  Article CAS PubMed PubMed Central Google Scholar
• Peeva E, Zouali M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett. 2005;101:123–43.
  Article CAS PubMed Google Scholar
• Legorreta-Haquet MV, Flores-Fernández R, Blanco-Favela F, Fuentes-Pananá EM, Chávez-Sánchez L, Hernández-González R, et al. Prolactin levels correlate with abnormal B cell maturation in MRL and MRL/lpr mouse models of systemic lupus erythematosus-like disease. Clin Dev Immunol. 2013;2013:287469.
  Article PubMed PubMed Central CAS Google Scholar
• Lavalle C, Loyo E, Paniagua R, Bermudez JA, Herrera J, Graef A, et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol. 1987;14:268–72.
  CAS PubMed Google Scholar
• Walker SE, Jacobson JD. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum Dis Clin N Am. 2000;26:713–36.
  Article CAS Google Scholar
• Jara LJ, Gomez-Sanchez C, Silveira LH, Martinez-Osuna P, Vasey FB, Espinoza LR. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci. 1992;303:222–6.
  Article CAS PubMed Google Scholar
• Jara LJ, Vera-Lastra O, Miranda JM, Alcala M, Alvarez-Nemegyei J. Prolactin in human systemic lupus erythematosus. Lupus. 2001;10:748–56.
  Article CAS PubMed Google Scholar
• Blanco-Favela F, Quintal-Alvarez G, Leaños-Miranda A. Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power. J Rheumatol. 1999;26:55–9.
  CAS PubMed Google Scholar
• Blanco-Favela F, Chavez-Rueda K, Leaños-Miranda A. Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus. Lupus. 2001;10:757–61.
  Article CAS PubMed Google Scholar
• Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda KA, Blanco-Favela F. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity. J Rheumatol. 2001;28:1546–53.
  PubMed Google Scholar
• Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus. 2001;10:554–61.
  Article CAS PubMed Google Scholar
• Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R. Elevated bioactive prolactin levels in systemic lupus erythematosus—association with disease activity. J Rheumatol. 2001;28:2216–21.
  CAS PubMed Google Scholar
• Miranda JM, Prieto RE, Paniagua R, Garcia G, Amato D, Barile L, et al. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. Lupus. 1998;7:387–91.
• Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza LR. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol. 1998;17:110–4.
  Article CAS PubMed Google Scholar
• Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, et al. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment. J Rheumatol. 2003;30:2140–6.
  CAS PubMed Google Scholar
• Rezaieyazdi Z, Hesamifard A. Correlation between serum prolactin levels and lupus activity. Rheumatol Int. 2006;26:1036–9.
  Article CAS PubMed Google Scholar
• Sugiura K, Muro Y, Watanabe A, Tomita Y. A case of systemic lupus erythematosus: continued association of circulating prolactin levels with disease activity over a 4-year follow-up period. Mod Rheumatol. 2005;15:220–2.
  Article PubMed Google Scholar
• Cardenas-Mondragon G, Ulloa-Aguirre A, Isordia-Salas I, Goffin V, Leaños-Miranda A. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays. J Rheumatol. 2007;34:1514–21.
  CAS PubMed Google Scholar
• Shabanova SS, Ananieva LP, Alekberova ZS, Guzov II. Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2008;26:436–41.
  CAS PubMed Google Scholar
• Silva CA, Deen ME, Febrônio MV, Oliveira SK, Terreri MT, Sacchetti SB, et al. Hormone profile in juvenile systemic lupus erythematosus with previous or current amenorrhea. Rheumatol Int. 2011;31:1037–43.
  Article CAS PubMed Google Scholar
• Paraiba DB, Soares CR, Bartolini P, Arthuso FS, Borba EF, Bonfa E, et al. Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia. Clin Exp Rheumatol. 2010;28:866–72.
  CAS PubMed Google Scholar
• Yang J, Li Q, Yang X, Li M. Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus. Lupus. 2016;25:513–9.
  Article CAS PubMed Google Scholar
• Legorreta-Haquet MV, Chávez-Rueda K, Chávez-Sánchez L, Cervera-Castillo H, Zenteno-Galindo E, Barile-Fabris L, et al. Function of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of Prolactin. Medicine (Baltimore). 2016;95:e2384. doi:10.1097/MD.0000000000002384.
• Toffoli Ribeiro C, Louzada Júnior P, de Sá MF. Correlation between systemic lupus erythematosus activity and plasma levels of monomeric prolactin and macroprolactin. Endocr Metab Immune Disord Drug Targets. 2016;16:21–7.
  Article PubMed CAS Google Scholar
• Orbach H, Zandman-Goddard G, Boaz M, Agmon-Levin N, Amital H, Szekanecz Z, et al. Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients. Clin Rev Allergy Immunol. 2012;42:189–98.
  Article CAS PubMed Google Scholar
• Zhang LN, Shi TY, Yang YJ, Zhang FC. An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine. Lupus. 2014;23:417–20.
  Article PubMed Google Scholar
• Nadira U, Cader RA, Kong NC, Mohd R, Gafor HA. Systemic lupus erythematosus with a non functioning pituitary macroadenoma. Am J Case Rep. 2012;13:160–2.
  Article PubMed PubMed Central Google Scholar
• Reuman PD. First reported pediatric case of systemic lupus erythematosus associated with prolactinoma. Arthritis Rheum. 2004;50:3616–8.
  Article PubMed Google Scholar
• Ugarte-Gil MF, Gamboa-Cárdenas RV, Zevallos F, Medina M, Cucho-Venegas JM, Perich-Campos RA, et al. High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients. Lupus. 2014;23:969–74.
  Article CAS PubMed Google Scholar
• Gutierrez MA, Molina JF, Jara LJ, Cuéllar ML, García C, Gutiérrez-Ureña S, et al. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus. 1995;4:348–52.
  Article CAS PubMed Google Scholar
• Larrea F, Martínez-Castillo A, Cabrera V, Alcocer-Varela J, Queipo G, Cariño C, et al. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J Clin Endocrinol Metab. 1997;82:3664–9.
  CAS PubMed Google Scholar
• Cruz J, Aviña-Zubieta A, Martínez de la Escalera G, Clapp C, Lavalle C. Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus. Arthritis Rheum. 2001;44:1331–5.
  Article CAS PubMed Google Scholar
• Leaños-Miranda A, Cardenas-Mondragon G. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Rheumatology (Oxford). 2006;45:97–101.
  Article Google Scholar
• Garcia M, Colombani-Vidal ME, Zylbersztein CC, Testi A, Marcos J, Arturi A, et al. Analysis of molecular heterogeneity of prolactin in human systemic lupus erythematosus. Lupus. 2004;13:575–83.
  Article CAS PubMed Google Scholar
• Montgomery DW. Prolactin production by immune cells. Lupus. 2001;10:665–75.
  Article CAS PubMed Google Scholar
• Mendez I, Alcocer-Varela J, Parra A, Lava-Zavala A, de la Cruz DA, Alarcón-Segovia D, et al. Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin. Lupus. 2004;13:45–53.
  Article CAS PubMed Google Scholar
• Huang X, Guo Y, Bao C, Shen N. Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity. PLoS One. 2011;6:e21671.
  Article CAS PubMed PubMed Central Google Scholar
• Gado K, Rimanóczi E, Hasitz A, Gigler G, Tóth BE, Nagy GM, et al. Elevated levels of serum prolactin in patients with advanced multiple myeloma. Neuroimmunomodulation. 2001;9:231–6.
  Article CAS PubMed Google Scholar
• Jacobi AM, Rohde W, Volk HD, Dörner T, Burmester GR, Hiepe F. Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls. Ann Rheum Dis. 2001;60:242–7.
  Article CAS PubMed PubMed Central Google Scholar
• Chavez-Rueda K, Legorreta-Haquet MV, Cervera-Castillo H, Sánchez L, Jara LJ, Zenteno E, et al. Prolactin effect on CD69 and CD154 expression by CD4+ cells from systemic lupus erythematosus patients. Clin Exp Rheumatol. 2005;23:769–77.
  CAS PubMed Google Scholar
• McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol. 1994;21:843–50.
  CAS PubMed Google Scholar
• Anaya JM, Shoenfeld Y. Multiple autoimmune disease in a patient with hyperprolactinemia. Isr Med Assoc J. 2005;7:740–1.
  PubMed Google Scholar
• Egli M, Leeners B, Kruger TH. Prolactin secretion patterns: basic mechanisms and clinical implications for reproduction. Reproduction. 2010;140:643–54.
  Article CAS PubMed Google Scholar
• Zen M, Ghirardello A, Iaccarino L, Tonon M, Campana C, Arienti S, et al. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly. 2010;140:187–201.
  CAS PubMed Google Scholar
• Crowley WR. Neuroendocrine regulation of lactation and milk production. Compr Physiol. 2015;5:255–91.
  PubMed Google Scholar
• Torner L, Toschi N, Nava G, Clapp C, Neumann ID. Increased hypothalamic expression of prolactin in lactation: involvement in behavioural and neuroendocrine stress responses. Eur J Neurosci. 2002;15:1381–9.
  Article PubMed Google Scholar
• Martinez-Garcia EA, Sánchez-Hernández PE, Chavez-Robles B, Nuñez-Atahualpa L, Martín-Márquez BT, Arana-Argaez VE, et al. The distribution of CD56(dim) CD16+ and CD56(bright) CD16- cells are associated with prolactin levels during pregnancy and menstrual cycle in healthy women. Am J Reprod Immunol. 2011;65:433–7.
  Article CAS PubMed Google Scholar
• Saavedra MA, Sánchez A, Morales S, Navarro-Zarza JE, Ángeles U, Jara LJ. Primigravida is associated with flare in women with systemic lupus erythematosus. Lupus. 2015;24:180–5.
  Article CAS PubMed Google Scholar
• Jara LJ, Medina G, Cruz-Dominguez P, Navarro C, Vera-Lastra O, Saavedra MA. Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res. 2014;60:184–92.
  Article CAS PubMed Google Scholar
• Jara-Quezada L, Graef A, Lavalle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol. 1991;18:349–53.
  CAS PubMed Google Scholar
• Doria A, Cutolo M, Ghirardello A, Zampieri S, Vescovi F, Sulli A, et al. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum. 2002;47:202–9.
  Article CAS PubMed Google Scholar
• Jara LJ, Pacheco-Reyes H, Medina G, Angeles U, Cruz-Cruz P, Saavedra MA. Prolactin levels are associated with lupus activity, lupus anticoagulant, and poor outcome in pregnancy. Ann N Y Acad Sci. 2007;1108:218–26.
  Article CAS PubMed Google Scholar
• Muñoz-Valle JF, Vázquez-Del Mercado M, García-Iglesias T, Orozco-Barocio G, Bernard-Medina G, Martínez-Bonilla G, et al. T(H)1/T(H)2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients. Clin Exp Immunol. 2003;131:377–84.
  Article PubMed PubMed Central Google Scholar
• Leaños-Miranda A, Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Parra A, Ramírez-Peredo J. Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome. Lupus. 2007;16:342-9.
• Jara LJ, Cruz-Cruz P, Saavedra MA, Medina G, García-Flores A, Angeles U, et al. Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial. Ann N Y Acad Sci. 2007;1110:297–304.
  Article CAS PubMed Google Scholar
• Qian Q, Liuqin L, Hao L, Shiwen Y, Zhongping Z, Dongying C, et al. The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South China. J Immunol Res. 2015;2015:316965.
  Article PubMed PubMed Central CAS Google Scholar
• McMurray RW, Keisler D, Izui S, Walker SE. Effects of parturition, suckling and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus. J Rheumatol. 1993;20:1143–51.
  CAS PubMed Google Scholar
• Berczi I. Prolactin, pregnancy and autoimmune disease. J Rheumatol. 1993;20:1095–100.
  CAS PubMed Google Scholar
• Levite M. Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases. Acta Physiol (Oxf). 2016;216:42–89.
  Article CAS Google Scholar
• Pacheco RF, Contreras F, Zouali M. The dopaminergic system in autoimmune diseases. Front Immunol. 2014;5:117.
  Article PubMed PubMed Central CAS Google Scholar
• Anderson KK, Ballok DA, Prasad N, Szechtman H, Sakic B. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice. Behav Brain Res. 2006;166:32–8.
  Article CAS PubMed Google Scholar
• Ballok DA, Earls AM, Krasnik C, Hoffman SA, Sakic B. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice. J Neuroimmunol. 2004;152:83–97.
  Article CAS PubMed Google Scholar
• Ferreira C, Paes M, Gouveia A, Ferreira E, Pádua F, Fiúza T. Plasma homovanillic acid and prolactin in systemic lupus erythematosus. Lupus. 1998;7:392–7.
  Article CAS PubMed Google Scholar
• Jafari M, Ahangari G, Saberi M, Samangoui S, Torabi R, Zouali M. Distorted expression of dopamine receptor genes in systemic lupus erythematosus. Immunobiology. 2013;218:979–83.
  Article CAS PubMed Google Scholar
• Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:273–88.
• Walker SE. Bromocriptine treatment of systemic lupus erythematosus. Lupus. 2001;10:762–8.
  Article CAS PubMed Google Scholar
• Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, Sosa-Muñoz J, Miranda JM, Jara LJ. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus. 1998;7:414–9.
  Article CAS PubMed Google Scholar
• McMurray RW, Weidensaul D, Allen SH, Walker SE. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol. 1995;22:2084–91.
  CAS PubMed Google Scholar
• Walker SE. Modulation of hormones in the treatment of lupus. Am J Manag Care. 2001;7:S486–9.
  CAS PubMed Google Scholar
• McMurray RW. Bromocriptine in rheumatic and autoimmune diseases. Semin Arthritis Rheum. 2001;31:21–32.
  Article CAS PubMed Google Scholar
• Hrycek A, Cieślik P, Tustanowski J, Nowak S, Jedynak P. Selected serum cytokines in systemic lupus erythematosus treated with quinagolide. Lupus. 2001;10:424–30.
  Article CAS PubMed Google Scholar
• Jara LJ, Medina G, Saavedra MA, Vera-Lastra O, Navarro C. Prolactin and autoimmunity. Clin Rev Allergy Immunol. 2011;40:50–9.
  Article CAS PubMed Google Scholar